GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Price-to-Tangible-Book

Curocell (XKRX:372320) Price-to-Tangible-Book : 8.94 (As of Oct. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Price-to-Tangible-Book?

As of today (2024-10-31), Curocell's share price is ₩29700.00. Curocell's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was ₩3,323.20. Hence, Curocell's Price to Tangible Book Ratio of today is 8.94.

The historical rank and industry rank for Curocell's Price-to-Tangible-Book or its related term are showing as below:

XKRX:372320' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 8.32   Med: 8.6   Max: 9.09
Current: 8.94

During the past 5 years, Curocell's highest Price to Tangible Book Ratio was 9.09. The lowest was 8.32. And the median was 8.60.

XKRX:372320's Price-to-Tangible-Book is ranked worse than
84.44% of 1189 companies
in the Biotechnology industry
Industry Median: 2.87 vs XKRX:372320: 8.94

A closely related ratio is called PB Ratio. As of today, Curocell's share price is ₩29700.00. Curocell's Book Value per Sharefor the quarter that ended in Jun. 2024 was ₩3,380.49. Hence, Curocell's P/B Ratio of today is 8.79.


Curocell Price-to-Tangible-Book Historical Data

The historical data trend for Curocell's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Price-to-Tangible-Book Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - - 8.32

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Tangible-Book - - - 8.32 8.88

Competitive Comparison of Curocell's Price-to-Tangible-Book

For the Biotechnology subindustry, Curocell's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curocell's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Curocell's Price-to-Tangible-Book falls into.



Curocell Price-to-Tangible-Book Calculation

Curocell's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=29700.00/3323.196
=8.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Curocell Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Curocell's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines